Clinical Practice Guideline of Korean Pancreatobiliary Association for Autoimmune Pancreatitis
9 affiliations
- 1Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea
- 2Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 3Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea
- 4Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
- 5Department of Internal Medicine, Inje University College of Medicine, Goyang, Korea
- 6Department of Internal Medicine, Hallym University College of Medicine, Anyang, Korea
- 7Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
- 8National Evidence-based Healthcare Collaborating Agency, Seoul, Korea
- 9Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea
Abstract
Autoimmune pancreatitis (AIP) is a distinct subtype of chronic pancreatitis characterized by immune-mediated inflammation and a favorable response to steroid therapy. Currently, the lack of standardized clinical practice guidelines in South Korea has led to significant variations in clinical practice, with diagnosis, steroid use, maintenance therapy, and relapse management often relying on individual clinicians’ experience and judgment. To address this issue, the Pancreas Research Group of the Korean Pancreatobiliary Association has developed a clinical practice guideline for the diagnosis, treatment, and follow-up of AIP, reflecting the latest global evidence and the specific healthcare environment in Korea. These recommendations were established through an extensive literature review and expert consensus using the Delphi method, with the level of evidence and strength of recommendation presented according to a standardized classification system. This clinical practice guideline aims to support consistent and rational clinical decision-making for patients with AIP and to provide a standard for evidence-based treatment suitable for the Korean medical context.
Related
- Association of Self-Reported Clinical Behavior With Guideline Adherence in Schizophrenia and Major Depressive Disorder After Guideline Education.
- Extrapancreatic Findings and Retrospective Diagnostic Pitfalls in Type 1 Autoimmune Pancreatitis: A Descriptive CT and MRI Study
- Tumor-associated Pancreatitis Mimicking Autoimmune Pancreatitis in a Young Male: A Case of Main Duct IPMC
- Antenatal diagnosis and classification for placenta accreta (adherence) spectrum: Clinical practice guideline and recommendations by the World Association of Perinatal Medicine and the Perinatal Medicine Foundation.
- A Case of Pancreaticobiliary Maljunction Associated with IgG4-related Sclerosing Cholangitis and Type 1 Autoimmune Pancreatitis
BibTeX
@article{chung2026clinical,
title = {{Clinical Practice Guideline of Korean Pancreatobiliary Association for Autoimmune Pancreatitis}},
author = {Kwang Hyun Chung and Kyu-Hyun Paik and Yun Chae Lee and Jin Ho Choi and Sung Woo Ko and Jun Hyuk Son and Dong Woo Shin and Min Je Sung and Kwangrok Jung and Miyoung Choi and Jaihwan Kim and Dong-Wan Seo},
journal = {Gut and Liver},
year = {2026},
month = nov,
doi = {10.5009/gnl260481},
url = {https://doi.org/10.5009/gnl260481},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Clinical Practice Guideline of Korean Pancreatobiliary Association for Autoimmune Pancreatitis
AU - Kwang Hyun Chung
AU - Kyu-Hyun Paik
AU - Yun Chae Lee
AU - Jin Ho Choi
AU - Sung Woo Ko
AU - Jun Hyuk Son
AU - Dong Woo Shin
AU - Min Je Sung
AU - Kwangrok Jung
AU - Miyoung Choi
AU - Jaihwan Kim
AU - Dong-Wan Seo
PY - 2026
DA - 2026/11/16
JO - Gut and Liver
DO - 10.5009/gnl260481
UR - https://doi.org/10.5009/gnl260481
AB - Autoimmune pancreatitis (AIP) is a distinct subtype of chronic pancreatitis characterized by immune-mediated inflammation and a favorable response to steroid therapy. Currently, the lack of standardized clinical practice guidelines in South Korea has led to significant variations in clinical practice, with diagnosis, steroid use, maintenance therapy, and relapse management often relying on individual clinicians’ experience and judgment. To address this issue, the Pancreas Research Group of the Korean Pancreatobiliary Association has developed a clinical practice guideline for the diagnosis, treatment, and follow-up of AIP, reflecting the latest global evidence and the specific healthcare environment in Korea. These recommendations were established through an extensive literature review and expert consensus using the Delphi method, with the level of evidence and strength of recommendation presented according to a standardized classification system. This clinical practice guideline aims to support consistent and rational clinical decision-making for patients with AIP and to provide a standard for evidence-based treatment suitable for the Korean medical context.
SN - 1976-2283
SN - 2005-1212
ER -